GGrantIndex
Sort

53,477 grants matching addiction

Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses

$533,283
Mary E McCaul · Johns Hopkins University · R01 · FY2011 · DA

Mechanisms driving lung cancer evolution during targeted kinase inhibitor treatment

$533,224
Aaron N Hata · Massachusetts General Hospital · R01 · FY2021 · CA

Development and Use of rtfMRI for Self-control of Nicotine Craving

$533,133
Jon-Kar Zubieta · University Of Michigan At Ann Arbor · R33 · FY2012 · DA

Predicting AOD Relapse and Treatment Completion from Social Media Use

$533,114
Brenda Curtis · University Of Pennsylvania · R01 · FY2015 · DA

TREATMENT OF ADULT ADHD IN METHADONE PATIENTS

$533,113
New York State Psychiatric Institute · R01 · FY2000 · DA

The National Drug Abuse Treatment Clinical Trials Network

$533,083
Roger D. Weiss · Mclean Hospital · UG1 · FY2018 · DA

Genomic and functional approaches to characterize Chr1q gains in cancer

$533,035
Jason Sheltzer · Yale University · R01 · FY2023 · CA

Licit & Illicit Opioids: Comparative Studies in Humans

$533,017
Sharon L. Walsh · University Of Kentucky · R01 · FY2006 · DA

Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes

$532,995
Kipling M Bohnert · Michigan State University · R01 · FY2024 · AA

Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery among People in Treatment for Opioid Use Disorder

$532,882
Valerie Ann Earnshaw · University Of Delaware · R01 · FY2025 · DA

Expanding Medication Assisted Therapies in Ukraine

$532,856
Frederick Lewis Altice · Yale University · R01 · FY2016 · DA

A Comparison of Buprenorphine Versus Morphine in the Treatment of the Neonatal Ab

$532,842
Walter K. Kraft · Thomas Jefferson University · R01 · FY2011 · DA

Analytical Services Center for Medications Development Program

$532,615
Yong Huang · University Of California, San Francisco · N01 · FY2014 · DA

Deep Brain Stimulation in the Parkinsonian Monkey

$532,605
Jerrold L Vitek · University Of Minnesota · R01 · FY2010 · NS

Deep Brain Stimulation in the Parkinsonian Monkey

$532,604
Jerrold L Vitek · University Of Minnesota · R01 · FY2012 · NS

Deep Brain Stimulation in the Parkinsonian Monkey

$532,603
Jerrold L Vitek · University Of Minnesota · R01 · FY2011 · NS

Compounded Neuronal Damage in Comorbid Cigarette Smoking and Addiction

$532,576
Karmen K Yoder · Indiana University Indianapolis · R01 · FY2020 · AA

Continuity of the Limbic Circuit Through the Basal Ganglia

$532,530
Suzanne N Haber · University Of Rochester · R01 · FY2017 · MH

Identifying specific genetic pathway interactions for drug use and abuse through integrative omics

$532,500
Qian Peng · Scripps Research Institute, The · DP1 · FY2021 · DA

Identifying specific genetic pathway interactions for drug use and abuse through integrative omics

$532,500
Qian Peng · Scripps Research Institute, The · DP1 · FY2022 · DA

Increasing the Capacity of a Community-Based Research Center to Address Opioid Use Disorder and Related Health Inequities in Urban American Indian Communities

$532,452
Antony Stately · Native American Community Clinic · OT2 · FY2025 · DA

Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking

$532,423
John R Mantsch · Marquette University · R01 · FY2018 · DA

Adoption of Innovations in Private A&D Treatment Centers

$532,420
Paul M Roman · University Of Georgia · R01 · FY2009 · DA

New Modalities for the Treatment of Pain and Drug Abuse

$532,410
Frank Porreca · University Of Arizona · P01 · FY2019 · DA

Domain-specific inhibition of angiotensin-converting enzyme as a therapeutic strategy for opioid use disorders

$532,385
Patrick Rothwell · University Of Minnesota · R01 · FY2025 · DA